|
This article is cited in 22 scientific papers (total in 22 papers)
Progress in the medical chemistry of organoboron compounds
A. N. Tevyashovaa, M. V. Chudinovb a G. F. Gause Institute of New Antibiotics, Russian Academy of Medical Sciences, Moscow
b MIREA — Russian Technological University, Moscow
Abstract:
The review aims to draw attention to the latest advances in the organoboron chemistry and therapeutic use of organoboron compounds. The synthetic strategies towards boron-containing compounds with proven in vitro and/or in vivo biological activities, including derivatives of boronic acids, benzoxaboroles, benzoxaborines and benzodiazaborines, are summarized. Approaches to the synthesis of hybrid structures containing an organoboron moiety as one of the pharmacophores are considered, and the effect of this modification on the pharmacological activity of the initial molecules is analyzed. On the basis of analysis of the published data, the most promising areas of research in the field of organoboron compounds are identified, including the latest methods of synthesis, modification and design of effective therapeutic agents.
The bibliography includes 246 references.
Keywords:
boronic acids, benzoxaboroles, benzoxaborines, benzodiazaborines, carboranes, boron clusters, borylation, drug design, biological activity, drug delivery systems, boron neutron capture therapy.
Received: 06.07.2020
Citation:
A. N. Tevyashova, M. V. Chudinov, “Progress in the medical chemistry of organoboron compounds”, Usp. Khim., 90:4 (2021), 451–487; Russian Chem. Reviews, 90:4 (2021), 451–487
Linking options:
https://www.mathnet.ru/eng/rcr4340https://doi.org/10.1070/RCR4977 https://www.mathnet.ru/eng/rcr/v90/i4/p451
|
Statistics & downloads: |
Abstract page: | 79 |
|